Skip to content

PHENIXFIN CORPORATION: 10-Q filed 2025-08-06

What PHENIXFIN CORPORATION reported in its quarterly report filed 2025-08-06 (fiscal Q3 2025): 20 published measures, 59 facts as tagged in accession 0001213900-25-072562.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-06
Fiscal period
fiscal Q3 2025
Accession
0001213900-25-072562 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHENIXFIN CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-30306,810,232USD
At 2024-09-30302,751,813USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-30150,116,113USD
At 2024-09-30142,444,040USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-30156,694,119USD
At 2025-03-31158,987,514USD
At 2024-09-30160,307,773USD
At 2024-06-30154,203,403USD
At 2024-03-31154,271,897USD
At 2023-09-30146,705,535USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-307,300,000USD
At 2024-09-3067,600,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-1,497,463USD91
2024-10-01 to 2025-06-3070,561USD273
2024-04-01 to 2024-06-302,608,611USD91
2023-10-01 to 2024-06-3012,514,752USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-10-01 to 2025-06-30-64,354,721USD273
2023-10-01 to 2024-06-307,393,169USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-10-01 to 2025-06-304,053,681USD273
2023-10-01 to 2024-06-30-4,514,873USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-547,421,557USD
At 2024-09-30-544,603,835USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,017,330shares91
2024-10-01 to 2025-06-302,018,962shares273
2024-04-01 to 2024-06-302,019,786shares91
2023-10-01 to 2024-06-302,047,127shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,017,330shares91
2024-10-01 to 2025-06-302,018,962shares273
2024-04-01 to 2024-06-302,019,786shares91
2023-10-01 to 2024-06-302,047,127shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.74USD/shares91
2024-10-01 to 2025-06-300.03USD/shares273
2024-04-01 to 2024-06-301.29USD/shares91
2023-10-01 to 2024-06-306.11USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.74USD/shares91
2024-10-01 to 2025-06-300.03USD/shares273
2024-04-01 to 2024-06-301.29USD/shares91
2023-10-01 to 2024-06-306.11USD/shares274

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,660,000USD91
2024-10-01 to 2025-06-307,785,000USD273
2024-04-01 to 2024-06-301,722,000USD91
2023-10-01 to 2024-06-304,831,000USD274

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2024-10-01 to 2025-06-30795,932USD273
2023-10-01 to 2024-06-302,370,959USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-302,003,869shares
At 2024-09-302,019,778shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-307,270,519USD
At 2024-09-3067,571,559USD
At 2024-06-308,866,519USD
At 2023-09-305,988,223USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-06-30190,743USD
At 2024-09-30294,063USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-06-3013,900,000USD
At 2024-09-3020,000,000USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2025-06-30340,531USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30398,494USD91
2024-10-01 to 2025-06-30928,026USD273
2024-04-01 to 2024-06-30226,903USD91
2023-10-01 to 2024-06-30862,740USD274

Inspect the source

Entity
PHENIXFIN CORPORATION / CIK 0001490349
Captured
2026-09-20T09:10:03.031Z
SEC response SHA-256
c28bfb7d18b72064e3bcf13c38b2db79d0056395ef33787396096dd974bf47a3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490349.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))